Skip to content

Ticagrelor

Its Antiplatelet Agent classification provides context for its listed use for Acute Coronary Syndrome. Readers can review the stated strength, presentation and ingredient details together in one focused catalogue view.

Brilinta

Acute Coronary Syndrome

90mg

Utilised to manage platelet aggregation to alleviate risk of vascular occlusion and support coronary circulation.

From$3.11/ tabletView

What treatment context is listed for Ticagrelor?

One listed use is Acute Coronary Syndrome. Another treatment context is Myocardial Infarction Prevention. Related medicines appear within Blood Thinners.

Important safety information for Ticagrelor

Information about Ticagrelor on this page is an educational overview, not medical advice. Products can differ in formulation, strength, and directions, and this content does not authorise clinical application or unsupervised use. Review the labelling for each product and speak with a healthcare professional whenever clinical judgement is needed. Product-specific contraindications, interactions, and reactions should be checked in the product labelling and verified clinical sources.